Keywords: مهار کننده های PDE5; PDE5 inhibitors; Prostate Cancer; Radical prostatectomy; Inhibiteurs de la Phosphodiesterase type 5; Cancer de la prostate; Prostatectomie totale;
مقالات ISI مهار کننده های PDE5 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده های PDE5; Pyrazolopyrimidinones; Sildenafil; PDE5 inhibitors; Erectile dysfunction; cGMP
Keywords: مهار کننده های PDE5; Erectile Dysfunction; PDE5 Inhibitors; Adherence; ED Causes
Keywords: مهار کننده های PDE5; Erectile Dysfunction; Health-Related Characteristics; Health-Related Quality of Life; PDE5 Inhibitors
Uso continuado de inhibidores de la PDE5 en el tratamiento de la disfunción eréctil: nuevas perspectivas y oportunidades
Keywords: مهار کننده های PDE5; Disfunción eréctil; Inhibidores de la fosfodiesterasa; Inhibidores de la PDE5; Erectile dysfunction; Phosphodiesterase inhibitors; PDE5 inhibitors;
Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors
Keywords: مهار کننده های PDE5; PDE5 inhibitors; Pyrroloquinolones; Bioavailability; Male erectile dysfunction (MED);
Discovery of furyl/thienyl β-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect
Keywords: مهار کننده های PDE5; β-Carboline derivatives; PDE5 inhibitors; Vasorelaxant effect; Structure-activity relationship;
The Role of PDE5 Inhibitors and the NO/cGMP Pathway in Cancer
Keywords: مهار کننده های PDE5; Cancer; PDE5 Inhibitors; cGMP; Melanoma; Myeloid-Derived Suppressor Cells; Chemotherapy;
Effets négatifs sur la sexualité des traitements médicamenteux des symptômes du bas appareil urinaire liés a l'hypertrophie bénigne de la prostate
Keywords: مهار کننده های PDE5; Symptômes du bas appareil urinaire; Hypertrophie bénigne de la prostate; Alpha-bloquants; Inhibiteurs de la 5-alpha-reductase; Inhibiteurs de la PDE5; Tadalafil; Dysfonction érectile; Troubles de l'éjaculation; Lower urinary tract symptoms; Benign p
Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia
Keywords: مهار کننده های PDE5; Congenital diaphragmatic hernia; DH; Pulmonary hypertension; Phosphodiesterase type 5 inhibitors; PDE5 inhibitors
The Efficacy of PDE5 Inhibitors Alone or in Combination with Alpha‐Blockers for the Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Meta‐Analysis
Keywords: مهار کننده های PDE5; Alpha‐Blockers; PDE5 Inhibitors; Erectile Dysfunction; Lower Urinary Tract Symptoms; Benign Prostatic Hyperplasia; Obstructive Urinary Symptoms; Meta‐Analysis; Randomized Controlled Trials
Exploration of the 5-bromopyrimidin-4(3H)-ones as potent inhibitors of PDE5
Keywords: مهار کننده های PDE5; PDE5 inhibitors; 5-Bromopyrimidin-4(3H)-ones;
Vardenafil Improves Penile Erection in Type 2 Diabetes Mellitus Patients with Erectile Dysfunction: Role of Tropomyosin
Keywords: مهار کننده های PDE5; Erectile Dysfunction; Diabetes Mellitus; PDE5 Inhibitors; Vardenafil; Proteomics
A Survey on Illegal and Counterfeit Medicines for the Treatment of Erectile Dysfunctions in Italy
Keywords: مهار کننده های PDE5; PDE5 Inhibitors; Counterfeit; Illegal Medicine
New Insights into the Pathophysiology of Sickle Cell Disease‐Associated Priapism
Keywords: مهار کننده های PDE5; eNOS; Nitric Oxide; Adenosine; Opiorphins; PDE5 inhibitors
Transient Rise of Serum Testosterone Level after Single Sildenafil Treatment of Adult Male Rats
Keywords: مهار کننده های PDE5; Testosterone; Sildenafil Citrate; cGMP; PDE5 Inhibitors; PRKG1; Leydig Cell;
Separate or Combined Treatments with Daily Sildenafil, Molsidomine, or MuscleâDerived Stem Cells Prevent Erectile Dysfunction in a Rat Model of Cavernosal Nerve Damage
Keywords: مهار کننده های PDE5; Stem Cells; Corporal VenoâOcclusive Dysfunction; Fibrosis; Corpora Cavernosa; PDE5 Inhibitors;
Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives
Keywords: مهار کننده های PDE5; PDE5 inhibitors; Tadalafil; Carbolines; Ensemble docking;
Treating Erectile Dysfunction and Central Neurological Diseases with Oral Phosphodiesterase Type 5 Inhibitors. Review of the Literature
Keywords: مهار کننده های PDE5; Erectile Dysfunction; PDE5 Inhibitors; Central Neurogenic Diseases; Spinal Cord Injury; Multiple Sclerosis; Parkinson's Disease
The Impact of Oral ED Medication on Female Partners' Relationship Satisfaction
Keywords: مهار کننده های PDE5; ED; Couples; Relationship; Female Partner; PDE5 Inhibitors;
Investigation of the pyrazinones as PDE5 inhibitors: Evaluation of regioisomeric projections into the solvent region
Keywords: مهار کننده های PDE5; PDE5 inhibitors; Pyrazinones; Lead optimization; Ligand efficiency; Lipophilic efficiency
Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro
Keywords: مهار کننده های PDE5; Nitric Oxide; CYP19; Estradiol; Tadalafil; Sildenafil; Endothelial Health; PDE5 Inhibitors; Human Visceral Adipocytes;
Improved Sexual Function with Testosterone Replacement Therapy in Hypogonadal Men: RealâWorld Data from the Testim Registry in the United States (TRiUS)
Keywords: مهار کننده های PDE5; Testosterone Replacement Therapy (TRT); Testosterone Gel; PDE5 Inhibitors; TRiUS Registry; Testim; Brief Male Sexual Function Inventory (BMSFI); Hypogonadism; Testosterone Deficiency; Erectile Dysfunction (ED);
Comparison of the First Intake of Vardenafil and Tadalafil in Patients with Diabetic Neuropathy and Diabetic Erectile Dysfunction
Keywords: مهار کننده های PDE5; Diabetic Neuropathy; Diabetic Erectile Dysfunction; PDE5 Inhibitors; First Intake of Tadalafil and Vardenafil; IIEF SEP2 SEP3 GAQ;
Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient
Keywords: مهار کننده های PDE5; Erectile Dysfunction; PDE5 Inhibitors; Tailored Treatment;
Expression of Cyclic AMP-dependent Protein Kinase Isoforms in Human Cavernous Arteries: Functional Significance and Relation to Phosphodiesterase Type 4
Keywords: مهار کننده های PDE5; Human Cavernous Arteries; Protein Kinase A; PDE5 Inhibitors; Vasculogenic Erectile Dysfunction;
Physical Activity and PDE5 Inhibitors in the Treatment of Erectile Dysfunction: Results of a Randomized Controlled Study
Keywords: مهار کننده های PDE5; Physical Activity; Sport; Exercise; Fitness; Treatment; Therapy; Erectile Dysfunction; PDE5 Inhibitors; Sildenafil; Tadalafil; Vardenafil;
Effects of Phosphodiesterase Inhibitors on the Inflammatory Response of Endothelial Cells Stimulated by Myeloperoxidase-Modified Low-Density Lipoprotein or Tumor Necrosis Factor Alpha
Keywords: مهار کننده های PDE5; Erectile dysfunction; Atherosclerosis; PDE5; PDE5 inhibitors; Myeloperoxidase; LDL; Mox-LDL
How Does Chronic Sildenafil Prevent Vascular Oxidative Stress in Insulin-Resistant Rats?
Keywords: مهار کننده های PDE5; Insulin Resistance; Pde5 Inhibitors; Oxidative Stress; Nitric Oxide; Superoxide; Endothelium;
REVIEW: Utilization of Pharmacotherapy for Erectile Dysfunction Following Treatment for Prostate Cancer
Keywords: مهار کننده های PDE5; Erectile Dysfunction; Prostate Cancer; Pharmacotherapy; PDE5 Inhibitors;
Acute Vardenafil Administration Improves Bladder Oxygenation in Spontaneously Hypertensive Rats
Keywords: مهار کننده های PDE5; Bladder Hypoxia; PDE5 Inhibitors; Bladder Overactivity; SHR; Bladder Smooth Muscle Cells;
Pharmacotherapy for Erectile Dysfunction
Keywords: مهار کننده های PDE5; Pharmacotherapy; Erectile Dysfunction; PDE5 Inhibitors;
Men's Sexual Health: Evaluating the Effectiveness of Print- and PDA-based CME
Keywords: مهار کننده های PDE5; Handheld; Enduring; Erectile Dysfunction; PDE5 Inhibitors; CME; PDA;
Prevention and Management of Postprostatectomy Erectile Dysfunction
Keywords: مهار کننده های PDE5; Prostate cancer; Erectile dysfunction; PDE5 inhibitors; Rehabilitation
Efficacy and Safety of Combined Oral Therapy with Tadalafil and Alfuzosin: An Integrated Approach to the Management of Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction. Preliminary Report
Keywords: مهار کننده های PDE5; Erectile Dysfunction; Lower Urinary Tract Symptoms; Alpha 1 Blockers; Tadalafil; Alfuzosin; PDE5 Inhibitors;
Ten Years of Phosphodiesterase Type 5 Inhibitors in Spinal Cord Injured Patients
Keywords: مهار کننده های PDE5; PDE5 Inhibitors; Erectile Dysfunction; Spinal Cord Injury; Neurology;
Timing of Dose Relative to Sexual Intercourse Attempt in Previous Sildenafil Citrate Users Treated with Tadalafil: A Geographical Comparison from a Single Arm, Open-Label Study
Keywords: مهار کننده های PDE5; Erectile Dysfunction; Sexual Behavior; Tadalafil; Sildenafil Citrate; Geography; PDE5 Inhibitors;
Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats
Keywords: مهار کننده های PDE5; PDE5 Inhibitors; Bladder Overactivity; Human Bladder Smooth Muscle Cells; ROCK Activity; Spontaneously Hypertensive Rats;
Erectile Dysfunction in Diabetes Mellitus
Keywords: مهار کننده های PDE5; Erectile Dysfunction; Diabetes; Hypogonadism; Testosterone; PDE5 Inhibitors; Pathophysilogy;
Giving Patients with Erectile Dysfunction the Opportunity to Try All Three Available Phosphodiesterase Type 5 Inhibitors Contributes to Better Long-Term Treatment Compliance
Keywords: مهار کننده های PDE5; Erectile Dysfunction; PDE5 Inhibitors; Long-Term Treatment Compliance; Patient Preference;
Acceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment in Patients following Bilateral Nerve-Sparing Radical Prostatectomy
Keywords: مهار کننده های PDE5; BNSRRP; Erectile dysfunction; PDE5 inhibitors; Prostate cancer; Radical prostatectomy; Therapy; Treatment
Long-Term Safety and Efficacy of Tadalafil 5 mg Dosed Once Daily in Men with Erectile Dysfunction
Keywords: مهار کننده های PDE5; Tadalafil; Once-Daily Dosing; Erectile Dysfunction; Safety; Efficacy; PDE5 Inhibitors;
The Role of PDE5 Inhibitors in Heme Oxygenase-cGMP Relationship in Rat Cavernous Tissues
Keywords: مهار کننده های PDE5; Heme oxygenase; cGMP; Sildenafil; Vardenafil; Tadalafil; PDE5 Inhibitors;
Combination of Alfuzosin and Tadalafil Exerts In Vitro an Additive Relaxant Effect on Human Corpus Cavernosum
Keywords: مهار کننده های PDE5; Erectile Dysfunction; PDE5 Inhibitors; α1-Blockers; Smooth Muscle; Pharmacology;
Oral Phosphodiesterase Type 5 Inhibitors: Nonerectogenic Beneficial Uses
Keywords: مهار کننده های PDE5; PDE5 Inhibitors; Sildenafil; Tadalafil; Vardenafil;
3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors
Keywords: مهار کننده های PDE5; PDE5 inhibitors; 3D-QSAR modeling; SK3530
Patients Responding to Phosphodiesterase Type 5 Inhibitor Therapy-What Do Their Sexual Partners Know?
Keywords: مهار کننده های PDE5; Erectile Dysfunction; PDE5 Inhibitors; Sexual Partner; Male Attitudes;
Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men
Keywords: مهار کننده های PDE5; Sildenafil; tadalafil; male fertility; PDE11; PDE5 inhibitors
Controversies in Sexual Medicine: Penile Rehabilitation Should Become the Norm for Radical Prostatectomy Patients
Keywords: مهار کننده های PDE5; Prostatectomy; PDE5 Inhibitors; Rehabilitation; Erectile Function;
Real-Life Safety and Efficacy of Vardenafil in the Treatment of Erectile Dysfunction-Results from 30,010 U.S. Patients
Keywords: مهار کننده های PDE5; Vardenafil; PDE5 Inhibitors; Erectile Dysfunction; Erection; First-Dose Success; Comorbidities;